Previous studies in hepatocellular carcinoma 29, 30 and breast cancer 10 patients have shown a similar phenomenon whereby tumor antigen‐specific CD8+ T cells demonstrated a lack of IFN‐γ production. This evidence concerns the gene IFNG and hepatocellular carcinoma.